Showing results (421-430 of 434) with videos related to
Sort By:
Pageof 44
Biochemical and Biophysical Research Communications|November 17, 2024
16S rRNA gene sequencing for bacterial identification and infectious disease diagnosisMei-Na Li, Qiang Han, Nan Wang, et al.Antonie Van Leeuwenhoek|July 16, 2024
A detailed analysis of 16S rRNA gene sequencing and conventional PCR-based testing for the diagnosis of bacterial pathogens and discovery of novel bacteriaMei-Na Li, Ting Wang, Nan Wang, et al.Human Vaccines & Immunotherapeutics|October 16, 2023
Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trialZhi-Wei Wu, Fei Jin, Qing-Liang Li, et al.Helicobacter|August 4, 2024
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth-Containing Quadruple Therapy as the First-Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled TrialYu-Ming Ding, Qiu-Mei Zhang, Rui-Li Li, et al.Life Sciences|April 26, 2023
Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathwayJia-Peng Lin, Mao-Hua Huang, Zhi-Ting Sun, et al.Medcomm|July 23, 2026
Targeting the NAT1-ENO1-Lactate Axis Destabilizes PD-L1 to Reinvigorate Antitumor Immunity in Colorectal CancerYi-Xuan Liu, Wen-Xin Wu, Yang Zang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2024
TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancerWen-Long Ye, Long Huang, Xiao-Qin Yang, et al.Digestive Diseases and Sciences|May 3, 2024
Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 DaysYu-Ming Ding, Miao Duan, Zhong-Xue Han, et al.European Journal of Endocrinology|April 14, 2018
The genetic characteristics of congenital hypothyroidism in China by comprehensive screening of 21 candidate genesFeng Sun, Jun-Xiu Zhang, Chang-Yi Yang, et al.Helicobacter|April 24, 2025
Seven-Day Versus 14-Day Tegoprazan and Tetracycline-Containing Quadruple Therapy for First-Line Eradication of Helicobacter pylori Infection: A Randomized, Open-Label, Noninferiority TrialXue-Ping Nan, Hong-Yu Zhao, Lei-Na Guo, et al.Pageof 44